Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,100
Closed -$2.49M 636
2023
Q2
$2.49M Buy
+22,100
New +$2.34M 0.05% 227
2022
Q4
Sell
-6,155
Closed -$538K 344
2022
Q3
$538K Buy
+6,155
New +$559K 0.01% 807

Other funds holding XYL

UBS O'Connor's XYL Position: Q3 2023 in Review

UBS O'Connor sold out of Xylem (XYL) in Q3 2023, closing a stake of 22,100 shares — an estimated $2.49M sold.

UBS O'Connor first reported a position in XYL in Q3 2022 and held it in 2 quarters. The position peaked at $2.49M in Q2 2023. 872 funds tracked by Wall St. Rank hold XYL as of Q3 2023.

  • UBS O'Connor reported no remaining Xylem position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 22,100 Xylem shares in Q3 2023, an estimated $2.49M.
  • UBS O'Connor first reported a position in Xylem in Q3 2022 and held it in 2 quarters.
  • UBS O'Connor's Xylem position peaked at $2.49M in Q2 2023.
  • 872 funds tracked by Wall St. Rank held Xylem as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.